Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$19.56 - $32.94 $11.8 Million - $19.8 Million
-602,225 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.73 - $36.04 $2.26 Million - $3.58 Million
99,299 Added 19.74%
602,225 $16.2 Million
Q2 2021

Aug 16, 2021

BUY
$22.2 - $42.29 $2.22 Million - $4.23 Million
100,000 Added 24.82%
502,926 $12.1 Million
Q1 2021

May 17, 2021

BUY
$35.94 - $52.67 $37,413 - $54,829
1,041 Added 0.26%
402,926 $17.5 Million
Q4 2020

Feb 16, 2021

BUY
$38.43 - $47.36 $15.4 Million - $19 Million
401,885 New
401,885 $16.7 Million

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $266M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.